Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations

Objective: To use a case-control study to assess and compare patterns of gray matter loss across groups of subjects with different mutations in the microtubule-associated protein tau (MAPT) gene. Methods: We identified all subjects from Mayo Clinic, Rochester, Minnesota, that screened positive for mutations in MAPT and had a head MRI (n = 22). Voxel-based morphometry was used to assess patterns of gray matter atrophy in groups of subjects with the IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M mutations compared with age- and sex-matched controls. Results: All MAPT groups showed gray matter loss in the anterior temporal lobes, with varying degrees of involvement of the frontal and parietal lobes. Within the temporal lobe, the subjects with IVS10+16, IVS10+3, N279K, and S305N mutations (mutations that influence the alternative splicing of tau pre–messenger RNA) all showed gray matter loss focused on the medial temporal lobes. In contrast to these groups, the subjects with P301L or V337M mutations (mutations that affect the structure of the tau protein) both showed gray matter loss focused on the lateral temporal lobes, with a relative sparing of the medial temporal lobe. Conclusion: There seem to be differences in patterns of temporal lobe atrophy across the MAPT mutations, which may aid in the differentiation of the different mutation carriers. Furthermore, there seems to be a possible association between mutation function and pattern of temporal lobe atrophy.

[1]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[2]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[3]  C. Broeckhoven,et al.  The role of tau (MAPT) in frontotemporal dementia and related tauopathies , 2004, Human mutation.

[4]  P. Rubé,et al.  L’examen Clinique en Psychologie , 1959 .

[5]  C. Jack,et al.  11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.

[6]  K. Josephs Frontotemporal dementia and related disorders: Deciphering the enigma , 2008, Annals of neurology.

[7]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[8]  Clifford R. Jack,et al.  Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease , 2005, NeuroImage.

[9]  T. Ishihara,et al.  Another phenotype of frontotemporal dementia and parkinsonism linked to chromosome-17 (FTDP-17) with a missense mutation of S305N closely resembling Pick’s disease , 2003, Journal of Neurology.

[10]  C. Jack,et al.  11 C PiB and structural MRI provide complementary information in imaging of Alzheimer ’ s disease and amnestic mild cognitive impairment , 2008 .

[11]  R A Crowther,et al.  Tau pathology in a family with dementia and a P301L mutation in tau. , 1999, Journal of neuropathology and experimental neurology.

[12]  Michel Goedert,et al.  Mutations causing neurodegenerative tauopathies. , 2005, Biochimica et biophysica acta.

[13]  K P Offord,et al.  A short test of mental status: description and preliminary results. , 1987, Mayo Clinic proceedings.

[14]  C. Jack,et al.  Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation. , 2005, Brain : a journal of neurology.

[15]  B. Boeve,et al.  Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). , 2007, Parkinsonism & related disorders.

[16]  C R Jack,et al.  Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN , 2009, Neurology.

[17]  E. Kaplan,et al.  The Boston naming test , 2001 .

[18]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[19]  I. Grundke‐Iqbal,et al.  Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations* , 2004, Journal of Biological Chemistry.

[20]  G. Schellenberg,et al.  A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) , 1999, Brain : a journal of neurology.

[21]  C. Duijn,et al.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. , 1999, American journal of human genetics.

[22]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[23]  D. Kareken,et al.  The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family , 2007, Brain : a journal of neurology.

[24]  E. Mandelkow,et al.  Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. , 2000, Biochemistry.

[25]  B. Boeve,et al.  Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). , 2008, Archives of neurology.

[26]  B. Snow,et al.  Rapidly progressive autosomal dominant parkinsonism and dementia with pallido‐ponto‐nigral degeneration , 1992, Annals of neurology.

[27]  D. Geschwind,et al.  Inheritance of frontotemporal dementia. , 1999, Archives of neurology.

[28]  Nick C Fox,et al.  Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. , 2005, Archives of neurology.

[29]  W. Kamphorst,et al.  Phenotypic variation in hereditary frontotemporal dementia with tau mutations , 1999, Annals of neurology.

[30]  T. Tabira,et al.  Familial frontotemporal dementia with a P301L tau mutation in Japan , 2000, Journal of the Neurological Sciences.

[31]  G. Schellenberg,et al.  A MAPT mutation in a regulatory element upstream of exon 10 causes frontotemporal dementia , 2006, Neurobiology of Disease.

[32]  R A Crowther,et al.  Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Mesulam,et al.  Slowly progressive aphasia without generalized dementia , 1982, Annals of neurology.

[34]  Y. Koshino,et al.  KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease. , 1999, Clinical neuropathology.